These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 18391925)
1. After microbicide failures, hope that antiviral approach will gel. Padma TV Nat Med; 2008 Apr; 14(4):354. PubMed ID: 18391925 [No Abstract] [Full Text] [Related]
2. AIDS research. Microbicide fails to protect against HIV. Cohen J Science; 2008 Feb; 319(5866):1026-7. PubMed ID: 18292313 [No Abstract] [Full Text] [Related]
3. HIV prevention in women: next steps. Vermund SH; Van Damme L Science; 2011 Jan; 331(6015):284. PubMed ID: 21252332 [No Abstract] [Full Text] [Related]
4. Vaginal microbicides: moving ahead after an unexpected setback. van de Wijgert JH; Shattock RJ AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873 [No Abstract] [Full Text] [Related]
5. Will vaginal microbicides solve the HIV problem in Africa? Muula AS Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863 [No Abstract] [Full Text] [Related]
6. The impact of microbicides and changes in condom usage on HIV prevalence in men and women. Chen FH AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411 [TBL] [Abstract][Full Text] [Related]
7. Promising anti-HIV gel in large-scale study in women. Expert Rev Anti Infect Ther; 2009 May; 7(4):395. PubMed ID: 19400755 [No Abstract] [Full Text] [Related]
8. The future of HIV microbicides: challenges and opportunities. Garg AB; Nuttall J; Romano J Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141 [TBL] [Abstract][Full Text] [Related]
9. Challenges of introducing vaginal microbicides in India. Joshi S; Kulkarni V; Paranjape R; Chandhiok N Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395 [No Abstract] [Full Text] [Related]
10. Microbicide research already benefiting thousands--experts. Bateman C S Afr Med J; 2009 Sep; 99(9):628-30. PubMed ID: 20073283 [No Abstract] [Full Text] [Related]
11. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064 [TBL] [Abstract][Full Text] [Related]
12. Microbicides: putting women in control. Forbes A WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770 [TBL] [Abstract][Full Text] [Related]
13. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. Lai BE; Geonnotti AR; Desoto MG; Montefiori DC; Katz DF Antiviral Res; 2010 Nov; 88(2):143-51. PubMed ID: 20709109 [TBL] [Abstract][Full Text] [Related]
14. The need for a "condoms-only" control group in microbicide trials. Jones H; van de Wijgert J; Kelvin E Epidemiology; 2003 Jul; 14(4):505; author reply 505-6. PubMed ID: 12843779 [No Abstract] [Full Text] [Related]
15. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287 [TBL] [Abstract][Full Text] [Related]
16. Trials of two microbicides to be launched in Africa. Pincock S BMJ; 2004 Apr; 328(7443):786. PubMed ID: 15070623 [No Abstract] [Full Text] [Related]
17. Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels. Lai BE; Henderson MH; Peters JJ; Walmer DK; Katz DF Biophys J; 2009 Nov; 97(9):2379-87. PubMed ID: 19883580 [TBL] [Abstract][Full Text] [Related]